AU2001229435A1 - Methods and compositions for obtaining disease protection for economically important animals - Google Patents

Methods and compositions for obtaining disease protection for economically important animals

Info

Publication number
AU2001229435A1
AU2001229435A1 AU2001229435A AU2943501A AU2001229435A1 AU 2001229435 A1 AU2001229435 A1 AU 2001229435A1 AU 2001229435 A AU2001229435 A AU 2001229435A AU 2943501 A AU2943501 A AU 2943501A AU 2001229435 A1 AU2001229435 A1 AU 2001229435A1
Authority
AU
Australia
Prior art keywords
compositions
methods
economically important
disease protection
important animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229435A
Inventor
Joseph M. Jilka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProdiGene Inc
Original Assignee
ProdiGene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProdiGene Inc filed Critical ProdiGene Inc
Publication of AU2001229435A1 publication Critical patent/AU2001229435A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001229435A 2000-01-14 2001-01-12 Methods and compositions for obtaining disease protection for economically important animals Abandoned AU2001229435A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17622000P 2000-01-14 2000-01-14
US60176220 2000-01-14
US19680900P 2000-04-13 2000-04-13
PCT/US2001/001148 WO2001051080A2 (en) 2000-01-14 2001-01-12 Methods and compositions for obtaining disease protection for animals

Publications (1)

Publication Number Publication Date
AU2001229435A1 true AU2001229435A1 (en) 2001-07-24

Family

ID=26872003

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229435A Abandoned AU2001229435A1 (en) 2000-01-14 2001-01-12 Methods and compositions for obtaining disease protection for economically important animals

Country Status (5)

Country Link
US (1) US20040191273A1 (en)
EP (1) EP1246929A2 (en)
AU (1) AU2001229435A1 (en)
CA (1) CA2397396A1 (en)
WO (1) WO2001051080A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3075392A4 (en) * 2013-11-26 2017-07-12 Idemitsu Kosan Co., Ltd. Prevention of escherichia coli diarrhea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
EP0793717B1 (en) * 1994-10-24 2005-01-26 The Texas A & M University System Oral immunization with transgenic plants

Also Published As

Publication number Publication date
CA2397396A1 (en) 2001-07-19
EP1246929A2 (en) 2002-10-09
WO2001051080A3 (en) 2002-04-18
WO2001051080A2 (en) 2001-07-19
US20040191273A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
AU4570901A (en) Biocidal methods and compositions
HUP0200075A3 (en) Antioxidant compositions and methods for companion animals
AU2001288458A1 (en) Methods for processing animal tissues
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU8911801A (en) Improved nanocomposite compositions and methods for making and using same
IL143423A0 (en) Insecticidal compositions and insecticidal methods
AU2001278919A1 (en) Transgenic animal and methods
EP1461047A4 (en) Compositions and methods for animal treatment
EP1370240A4 (en) Neuroprotectants formulations and methods
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
AU2002358036A1 (en) Methods and compositions for use in pet breeding
IL153487A0 (en) Pharmaceutical compositions and methods for use
AU2001247196A1 (en) Methods and compositions for detection of disease
IL153897A0 (en) Pharmaceutical compositions and methods for use
GB0018769D0 (en) Antioxidant compositions and methods for companion animals
EP1169034A4 (en) Decursinol or derivative thereof as analgesic agent
AU2001229435A1 (en) Methods and compositions for obtaining disease protection for economically important animals
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
GB2378135B (en) Compositions derived from modiolus modiolus and methods for making and using same
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001252781A1 (en) Animal trap
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU8342001A (en) Pseudomycins useful against plant diseases
GB2367493B (en) Composition and method for deterring rodents
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease